This is the final installment of our 4-part series, "Trading Traditional Topicals for Targeted Therapies: Improving Disease Management for AD." In this episode, "Moving into the Non-Steroidal Topical Therapy Age," we dive into the current and emerging landscape of targeted topical therapies for AD patients. Our experts review the latest clinical data, discuss how they are practically integrating these agents into their practice, and analyze the resulting impact on patient outcomes and their overall approach to AD management. Listen in as board-certified dermatologists, Mona Shahriari, MD and G. Michael Lewitt, MD discuss:
Overview of targeted topical therapies, including next generation topicals
Efficacy of targeted topicals compared to topical steroids
Safety, limitations, and compatibility with other therapies
How to integrate targeted topicals into clinical practice
Pearls for treating pediatric and adult patients across the indicated age range
This podcast is supported by an educational grant from Arcutis Biotherapeutics, Inc.
